| Autor: |
I. V. Andryushchenko, H. H. Valiullin |
| Jazyk: |
ruština |
| Rok vydání: |
2015 |
| Předmět: |
|
| Zdroj: |
Стратегии бизнеса, Vol 0, Iss 8 (2015) |
| Druh dokumentu: |
article |
| ISSN: |
2311-7184 |
| DOI: |
10.17747/2311-7184-2015-8-1 |
| Popis: |
The Russia's pharmaceutical market is one of the most oriented on imported products. In particular, dependence of domestic insulin market from foreign production is now higher than 90%. The Western sanctions against Russia create a serious threat of the relevant drugs shortage. These conditions give the priority to the development of domestic biopharmaceutic technologies especially in SEZ. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
